The presence of mutations in IDH1 and IDH2 early in disease pathogenesis in malignant gliomas, myeloid malignancies, and cartilaginous tumors underscores the magnitude of the role of IDH1 and IDH2 mutations in tumorigenesis [18, 19]. The gene discussed is IDH2; the disease is malignant glioma.